Downregulation of Matrix Metalloproteinases and Collagens and Suppression of Cardiac Fibrosis by Inhibition of the Proteasome

No abstract is available for this paper.

• Publication year

  2004

• Venue

  HYPERTENSION

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.HYP.0000142772.71367.65PMID 15337735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ac-SDKP Reverses Inflammation and Fibrosis in Rats With Heart Failure After Myocardial Infarction

  2004cited by this paper
• Inhibition of Proteasome Activity Induces Concerted Expression of Proteasome Genes and de Novo Formation of Mammalian Proteasomes*

  2003cited by this paper
• Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.

  2003cited by this paper
• The compressed feature matrix—a fast method for feature based substructure search

  2003cited by this paper
• Regression of Hypertensive Myocardial Fibrosis by Na+/H+ Exchange Inhibition

  2003cited by this paper
• Proteasome inhibition: a new anti-inflammatory strategy

  2003cited by this paper
• Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis

  2002cited by this paper
• Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection.

  2002cited by this paper
• Molecular sequelae of proteasome inhibition in human multiple myeloma cells

  2002cited by this paper
• Matrix metalloproteinases: regulation and dysregulation in the failing heart.

  2002cited by this paper
• MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure.

  2002cited by this paper
• Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in &bgr;1-Adrenergic Receptor Transgenic Mice

  2002cited by this paper
• Ubiquitin-Proteasome Pathway as a New Target for the Prevention of Restenosis

  2002cited by this paper
• Tumor Necrosis Factor α Induces Expression of Genes for Matrix Degradation in Human Chondrocyte‐like HCS‐2/8 Cells Through Activation of NF‐κB: Abrogation of the Tumor Necrosis Factor α Effect by Proteasome Inhibitors

  2001cited by this paper
• Matrix metalloproteinase inhibition and the prevention of heart failure.

  2001cited by this paper
• Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells.

  2001cited by this paper
• Regulation of Cardiac Collagen: Angiotensin and Cross-Talk With Local Growth Factors

  2001cited by this paper
• Downregulation of Matrix Metalloproteinases and Reduction in Collagen Damage in the Failing Human Heart After Support With Left Ventricular Assist Devices

  2001cited by this paper
• Proteasome inhibitors: from research tools to drug candidates.

  2001cited by this paper
• TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP.

  2001cited by this paper
• Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.

  2000cited by this paper
• Amplification of IL-1β-Induced Matrix Metalloproteinase-9 Expression by Superoxide in Rat Glomerular Mesangial Cells Is Mediated by Increased Activities of NF-κB and Activating Protein-1 and Involves Activation of the Mitogen-Activated Protein Kinase Pathways1

  2000cited by this paper
• Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.

  2000cited by this paper
• Interleukin-1β and Tumor Necrosis Factor-α Decrease Collagen Synthesis and Increase Matrix Metalloproteinase Activity in Cardiac Fibroblasts In Vitro

  2000cited by this paper
• Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

  2000cited by this paper
• Endothelin system-dependent cardiac remodeling in renovascular hypertension.

  1999cited by this paper
• The 26S proteasome: a molecular machine designed for controlled proteolysis.

  1999cited by this paper
• Involvement of proteasomes in migration and matrix metalloproteinase‐9 production of oral squamous cell carcinoma

  1998cited by this paper
• Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Ventricular remodeling in heart failure: the role of myocardial collagen.

  1995cited by this paper
• Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats.

  1995cited by this paper
• The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

  1994cited by this paper
• Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

  1993cited by this paper
• Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.

  1991cited by this paper
• Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular Hypertrophy

  1991cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper

• Soluble CD147 regulates endostatin via its effects on the activities of MMP-9 and secreted proteasome 20S

  2024cites this paper
• Modulating adipose-derived stromal cells' secretomes by culture conditions: effects on angiogenesis, collagen deposition, and immunomodulation

  2024cites this paper
• Interferon-β decreases LPS-induced neutrophil recruitment to cardiac fibroblasts

  2023cites this paper
• Ubiquitin like protein FAT10 repressed cardiac fibrosis after myocardial ischemic via mediating degradation of Smad3 dependent on FAT10-proteasome system

  2023cites this paper
• Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis

  2022cites this paper
• Comprehensive Bioinformatics Analysis to Reveal Key RNA Targets and Hub Competitive Endogenous RNA Network of Keratoconus

  2022cites this paper
• Hsp90 Inhibitor Attenuates the Development of Pathophysiological Cardiac Fibrosis in Mouse Hypertrophy via Suppression of the Calcineurin-NFAT and c-Raf-Erk Pathways

  2021cites this paper
• Resveratrol against Cardiac Fibrosis: Research Progress in Experimental Animal Models

  2021cites this paper
• Bortezomib limits renal allograft interstitial fibrosis by inhibiting NF-κB/TNF-α/Akt/mTOR/P70S6K/Smurf2 pathway via IκBα protein stabilization.

  2020cites this paper
• A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin–Proteasome System in Pulmonary Fibrosis

  2020cites this paper
• Effects of proteasome inhibitors on cytokines, metalloproteinases and their inhibitors and collagen type-I expression in periprosthetic tissues and fibroblasts from loose arthroplasty endoprostheses

  2019cites this paper
• Altered proteasome function in right ventricular hypertrophy.

  2019cites this paper
• Ankyrin-B: proteostasis and impact on cardiomyocyte behaviours in H9c2 cells

  2018cites this paper
• Hypertension: a new treatment for an old disease? Targeting the immune system

  2018cites this paper
• Impact of proteasome inhibitor MG-132 on expression of NF-κB, IL-1β and histological remodeling after myocardial infarction.

  2018cites this paper
• Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload

  2018cites this paper
• The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis

  2018cites this paper
• Protective Effect and Potential Mechanism of Simvastatin on Myocardial Injury Induced by Diabetes with Hypoglycemia.

  2017cites this paper
• Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7

  2017cites this paper
• MicroRNA: A new therapeutic strategy for cardiovascular diseases.

  2016cites this paper
• Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells

  2016cites this paper
• Regulation of 26S Proteasome Activity in Pulmonary Fibrosis.

  2015cites this paper
• Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease.

  2015cites this paper
• miR-146a targets Fos expression in human cardiac cells

  2015cites this paper
• Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis

  2015cites this paper
• Aberrant TGFβ/BMP signalling in connective tissue disease associated pulmonary hypertension

  2015cites this paper
• Aerobic exercise training improves oxidative stress and ubiquitin proteasome system activity in heart of spontaneously hypertensive rats

  2015cites this paper
• Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP.

  2015cites this paper
• Nigrostriatal pathway degeneration in rats after intraperitoneal administration of proteasome inhibitor MG-132.

  2014cites this paper
• Regulation of the Proteasome: Evaluating the Lung Proteasome as a New Therapeutic Target

  2014cites this paper
• Bortezomib, a Proteasome Inhibitor, Attenuates Angiotensin II-Induced Hypertension and Aortic Remodeling in Rats

  2013influential citation
• Effect of common dietary fatty acids on viability and fibrosis of cardiac cells

  2013cites this paper
• Habilitationsschrift Molekulare Grundlagen der protektiven Effekte von Proteasominhibitoren im kardiovaskulären System

  2013cites this paper
• Molekulare Grundlagen der protektiven Effekte von Proteasominhibitoren im kardiovaskulären System

  2013cites this paper
• Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.

  2013cites this paper
• Effect of proteasome inhibitor 1 on wound healing: a potential scar prevention therapy.

  2013cites this paper
• Therapeutic Effect of MG132 on the Aortic Oxidative Damage and Inflammatory Response in OVE26 Type 1 Diabetic Mice

  2013cites this paper
• MicroRNA-21 in Scleroderma Fibrosis and its Function in TGF-β- Regulated Fibrosis-Related Genes Expression

  2013cites this paper
• Regulation of Cardiac Hypertrophic Remodeling by the USP15/SLIM1 Pathway

  2013cites this paper
• Primary proteasome inhibition results in cardiac dysfunction

  2013cites this paper
• Long-term intake of sesamin improves left ventricular remodelling in spontaneously hypertensive rats.

  2013cites this paper
• Protein degradation by the ubiquitin-proteasome pathway and organ fibrosis.

  2012cites this paper
• Proteasome Inhibition Reduces Proliferation, Collagen Expression, and Inflammatory Cytokine Production in Nasal Mucosa and Polyp Fibroblasts

  2012cites this paper
• Low dose proteasome inhibition affects alternative splicing.

  2012cites this paper
• TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-кB pathway

  2012cites this paper
• What shall we do with the damaged proteins in lung disease? Ask the proteasome!

  2012cites this paper
• Proteasome Inhibition Prevents Development of Experimental Dermal Fibrosis

  2012cites this paper
• Targeting the tumor proteasome as a mechanism to control the synthesis and bioactivity of matrix macromolecules.

  2012cites this paper
• Matrix metalloproteinase-2 stimulates collagen-I expression through phosphorylation of focal adhesion kinase in rat cardiac fibroblasts.

  2012cites this paper
• Autophagy Promotes Intracellular Degradation of Type I Collagen Induced by Transforming Growth Factor (TGF)-β1*

  2012cites this paper
• The Ubiquitin Proteasome System in Endothelial Cell Dysfunction and Vascular Disease

  2012cites this paper
• Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis.

  2011cites this paper
• Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy

  2011cites this paper
• MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathway.

  2011cites this paper
• Der Einfluss des Proteasominhibitors Bortezomib auf die kardiale Hypertrophie in der Dahl Salz-sensitiven Ratte

  2011cites this paper
• Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β1 signalling

  2011cites this paper
• Effect of Inhibition of the Ubiquitin-Proteasome-System and IκB Kinase on Airway Inflammation and Hyperresponsiveness in a Murine Model of Asthma

  2011cites this paper
• Preventive Effect of a Proteasome Inhibitor on the Formation of Accelerated Atherosclerosis in Rabbits With Uremia

  2010cites this paper
• The Role of the Transcription Factor Nuclear Factor Kappa B in the Regulation of Cardiac Hypertrophy

  2010cites this paper
• On to the road to degradation: atherosclerosis and the proteasome.

  2010cites this paper
• Functional alterations of cardiac proteasomes under physiological and pathological conditions.

  2010cites this paper
• Proteasome inhibitors and cardiac cell growth.

  2010cites this paper
• Extracellular matrix alterations in hypertensive vascular remodeling.

  2010cites this paper
• Proteasomal regulation of pulmonary fibrosis.

  2010cites this paper
• Cancer esearch or and Stem Cell Biology age-Gated Na + Channel SCN 5 A Is a Key Regulator of a e Transcriptional Network That Controls Colon R cer Invasion

  2010cites this paper
• Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion.

  2010cites this paper
• Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts

  2010cites this paper
• Proteasome inhibition prevents experimentally-induced endothelial dysfunction.

  2009cites this paper
• Klonierung und funktionelle Analyse der 5'-flankierenden Region des humanen kardialen ERα-Gens

  2009cites this paper
• Transcriptional regulation of the pro-apoptotic gene Bnip3 by P65 NF-κB, Histone Deacetylase 1, and E2F-1 in postnatal ventricular myocytes

  2009cites this paper
• Inhibitors of the Ubiquitin-Proteasome System as Potential Therapeutic Agents for Cardiovascular Diseases

  2008cites this paper
• Atrial Gap Junctions, NF-κB and Fibrosis in Patients Undergoing Coronary Artery Bypass Surgery: The Relationship with Postoperative Atrial Fibrillation

  2008cites this paper
• Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload.

  2008cites this paper
• Proteasome inhibitors: Poisons and remedies

  2008cites this paper
• Downregulation of MMP-2 and -9 by proteasome inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opacification.

  2008cites this paper
• Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease.

  2008cites this paper
• Characteristics of Catechin- and Theaflavin-Mediated Cardioprotection

  2008cites this paper
• Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.

  2008influential citation
• In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis.

  2008cites this paper
• Inhibitors of the Ubiquitin-Proteasome System asPotential Therapeutic Agents for Cardiovascular Diseases

  2008cites this paper
• Ubiquitin Carboxyl-Terminal Hydrolase L1, a Novel Deubiquitinating Enzyme in the Vasculature, Attenuates NF-&kgr;B Activation

  2007cites this paper
• Sex differences in myocardial infarction and rupture.

  2007cites this paper
• Ubiquitination and Degradation of the Anti-apoptotic Protein ARC by MDM2*

  2007cites this paper
• The Role of Myocardial Collagen Network in Hypertensive Heart Disease

  2007cites this paper
• Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts.

  2007cites this paper
• Alteraciones del metabolismo del colágeno fibrilar en la cardiopatía hipertensiva. Situación actual y perspectivas

  2006cites this paper
• [Altered fibrillar collagen metabolism in hypertensive heart failure. Current understanding and future prospects].

  2006cites this paper
• Regulating the regulator: NF-kappaB signaling in heart.

  2006cites this paper
• Proteasome blockade exerts an antifibrotic activity by coordinately down‐regulating type I collagen and tissue inhibitor of metalloproteinase‐1 and up‐regulating metalloproteinase‐1 production in human dermal fibroblasts

  2006influential citation
• Aldosterone mediates angiotensin II‐induced interstitial cardiac fibrosis via a Nox2‐containing NADPH oxidase

  2006cites this paper
• Consecuencias clínicas de la fibrosis miocárdica en la cardiopatía hipertensiva

  2006cites this paper
• Mechanisms of Disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease

  2005cites this paper
• The ubiquitin‐proteasome system—micro target for macro intervention?

  2005cites this paper
• New directions in the assessment and treatment of hypertensive heart disease

  2005cites this paper